Delivery Order SPE2DR25D1053-SPE2DR26FU048
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,170.56 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded a $1,148.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg, with a completion date of September 12, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be delivered...
- The Defense Logistics Agency awarded a $1,422.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 10 mg on November 10, 2025, with completion scheduled for November 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,062.60 for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a $1,052.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 18, 2025, with completion scheduled for September 19, 2025. This competitive award, which carried no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.67 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $1,127.41 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,498.56 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on November 5, 2025, with completion scheduled for November 6, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, representing a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency awarded a delivery order valued at $1,836.31 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg, with an ultimate completion date of October 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FU048Delivery Order
The Defense Logistics Agency awarded a $3,082.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on November 20, 2025, with an ultimate completion date of November 21, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply role supporting federal military and veteran healthcare systems. As a major pharmaceutical distributor and critical vendor for DLA's medical supply chain, the company maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The delivery order demonstrates the flexibility of the IDC vehicle, which enables AmerisourceBergen to fulfill diverse pharmaceutical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/20/25 |